Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. (Q45806334)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

1 reference

chronic lymphocytic leukemia

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Lukáš Smolej

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Eduard Cmunt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Michael Doubek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jiří Mayer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Petra Obrtlíková

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jiří Schwarz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Martin Brejcha

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Petr Kozmon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sárka Pospíšilová

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Yvona Brychtová

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Zdeněk Pospíšil

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

130-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

The clinical and epidemiological burden of chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Richter syndrome: molecular insights and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2011.01639.X

10.1111/J.1600-0609.2011.01639.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21535162%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference